• 4238 Citations
  • 31 h-Index
1984 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicola Cascavilla is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 64 Similar Profiles
Stem Cell Transplantation Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
fotemustine Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

  • 4238 Citations
  • 31 h-Index
  • 188 Article
  • 2 Letter
  • 1 Review article
1 Citation (Scopus)

Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients

Gaudio, F., Mazza, P., Mele, A., Palazzo, G., Carella, A. M., Delia, M., Pisapia, G., Pastore, D., Cascavilla, N., Pavone, V. & Specchia, G., Jan 1 2019, In : Annals of Hematology.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Hodgkin Disease
Survival
Graft vs Host Disease
Disease-Free Survival

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., 2019, In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Broccoli, A., Casadei, B., Chiappella, A., Visco, C., Tani, M., Cascavilla, N., Conconi, A., Balzarotti, M., Cox, M. C., Marino, D., Goldaniga, M. C., Marasca, R., Tecchio, C., Patti, C., Musuraca, G., Devizzi, L., Monaco, F., Romano, A., Fama, A., Zancanella, M. & 6 others, Paolini, R., Rigacci, L., Castellino, C., Gaudio, F., Argnani, L. & Zinzani, P. L., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Multicenter Studies
Retrospective Studies
Non-Hodgkin's Lymphoma
Therapeutics

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs

Montefusco, V., Gay, F., Spada, S., De Paoli, L., Di Raimondo, F., Ribolla, R., Musolino, C., Patriarca, F., Musto, P., Galieni, P., Ballanti, S., Nozzoli, C., Cascavilla, N., Ben-Yehuda, D., Nagler, A., Hajek, R., Offidani, M., Liberati, A. M., Sonneveld, P., Cavo, M. & 2 others, Corradini, P. & Boccadoro, M., Jun 20 2019, In : Haematologica.

Research output: Contribution to journalArticle

Multiple Myeloma
Pharmaceutical Preparations
Disease-Free Survival
Proteasome Inhibitors
Multivariate Analysis